No-Cost, No-Obligation Louisiana AndroGel Lawsuit Review


Bookmark and Share

Louisiana Testosterone Heart Attack Lawsuits

Louisiana AndroGel Lawsuits - Attorneys Handling Louisiana Testosterone Lawsuits for Heart Attack and Stroke Provide Free, No-Obligation Louisiana AndroGel Lawsuit Evaluation

Louisiana AndroGel Lawyer

Testosterone replacement therapy increases men’s risk of a serious cardiac event, including heart attack and stroke, by two to three times. Lawyers handling Louisiana AndroGel testosterone lawsuits say AbbVie and other drug companies made false claims about the product’s efficacy and glossed over the dangers of heart attack and stroke. Many men taking testosterone drugs such as AndroGel are doing so based on unproven advertising claims that hormone replacement therapy can offset normal aspects of aging.

Endocrinologists caution that a majority of men taking AndroGel do not have genuine hypogonadism, the condition for which testosterone therapy is medically indicated. Using testosterone replacement therapy without medical indication exposes men to severe and fatal risks without the promise of scientifically-proven advantages. Louisiana AndroGel lawsuits allege that men taking testosterone drugs were not adequately warned of the potential for heart attack and stroke.

Filing a testosterone lawsuit in Louisiana may be the most effective method for Louisiana consumers to demand corporate accountability for the injustices done to men who have had heart attacks or strokes while taking AndroGel. If you or a man in your family in Louisiana suffered from a serious cardiac problem while using a testosterone supplement, Louisiana AndroGel attorneys believe you may be eligible to file a claim for damages, harm, or loss suffered as a result of a heart attack or stroke. The Louisiana AndroGel Testosterone Lawsuits website brings needed information to the public on heart attack and stroke claims, including information on testosterone FDA warnings, how to choose a Louisiana AndroGel heart attack or stroke lawyer, and how to file a testosterone stroke or heart attack lawsuit in Louisiana.


Louisiana Testosterone Lawyer Heart Attack and Stroke

Louisiana AndroGel Lawsuits

Individuals in Louisiana who have suffered stroke, heart attack, or other cardiac problems while taking AndroGel or a similar testosterone product may qualify to file an Louisiana AndroGel lawsuit. A group of men filed testosterone lawsuits in early 2014 against AbbVie, saying the drug maker failed to warn consumers of heart attack and stroke risks. Persons filing AndroGel lawsuits in Louisiana can expect real compensation for the damages and loss caused by stroke and heart attack. This page features information on finding a lawyer and filing a Louisiana testosterone lawsuit.



Louisiana Testosterone Lawsuit FAQ

Louisiana AndroGel Lawsuit FAQs

The Louisiana AndroGel Lawsuit FAQs page features answers to common questions regarding claims for heart attack and stroke. Many families wonder who qualifies to file a Louisiana testosterone lawsuit and what kind of compensation can be expected from heart attack and stroke claims. Filing a testosterone claim in Louisiana can help increase pharmaceutical company accountability, and provides meaningful compensation for men and the families of men in Louisiana who have been harmed by testosterone products. This page provides information about Louisiana testosterone lawsuit time limits that may apply to you.



Unaware of Cardiac Risks, More Men Are Taking Testosterone Supplements than Ever Before

Prescriptions for AndroGel and other testosterone-boosting drugs have been on the rise in Louisiana and throughout the United States for the past decade. The number of testosterone prescribers has tripled since 2001, in large part thanks to aggressive marketing campaigns that prey on men’s natural anxieties over aging. The “disease awareness” marketing campaigns for “Low-T” reach far beyond the FDA approval for hypogonadism, encouraging men with slight ailments to self-diagnose and request a prescription. Today, testosterone products are among the most prescribed drugs around the globe, yielding billions in profits to large pharmaceutical corporations. Three million American men prescribed to AndroGel alone during 2012. Total U.S. sales of testosterone supplements exceeded $2 billion in 2012, and are expected to grow to $5 billion by 2017.

Hypogonadism, the only condition for which AndroGel has been approved, is characterized by a severe lack of natural serum testosterone, must be diagnosed via blood tests, and can result in significant health problems. Researchers say as many as 50% of men taking testosterone have never been tested for low testosterone. Millions of men in Louisiana and throughout the nation may be taking AndroGel and similar drugs unnecessarily.

Louisiana AndroGel lawsuits assert that the drug makers have not adequately warned consumers of the testosterone heart attack and stroke risks, despite the existence of research proving the AndroGel heart attack link. Endocrinology experts say advertising budgets to promote testosterone replacement therapies far outweigh money spent on research of testosterone risks. Testosterone products are now the subject of warnings from the FDA and Consumer Reports based on heart attack and stroke risks.

FDA Testosterone Warning

FDA Testosterone Warning Prompts Lawsuits

On January 31, 2014, a FDA testosterone warning for heart attack and stroke risks. The warning was issued on the basis of new research in late 2013 and early 2014, confirming earlier findings that taking AndroGel increases a man’s risk for heart attack and stroke as much as two or three times the ordinary rate. While the FDA testosterone warning does not say patients should stop taking the drug, it does caution clinicians to carefully consider the drug’s side effects before prescribing AndroGel. In many cases, the cardiac risks posed by the medication may vastly outweigh potential benefits.

In the days following the release of the FDA AndroGel Warning, numerous lawsuits were filed against AbbVie, asserting that patients who have suffered from stroke or heart attack were not warned of the cardiac risks posed by the drug. In many cases, men may have chosen not to take testosterone if they had known it posed fatal health risks.